Template:Further points for assessing the study: Difference between revisions
Appearance
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
|- | |- | ||
! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis | ! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis | ||
| style="text-align:center | | style="text-align:center;" | [[Reasons given for samples being too small according to power analysis::{{{Reasons given for samples being too small according to power analysis|}}}]] | ||
|- | |- | ||
! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm) | ! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm) | ||
Line 27: | Line 27: | ||
|- | |- | ||
! style="text-align:left; text-indent:3em;" | - Possibility of attention effects | ! style="text-align:left; text-indent:3em;" | - Possibility of attention effects | ||
| [[Possibility of attention effects::{{{Possibility of attention effects|}}}]] | |||
|- | |- | ||
! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects | ! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects | ||
| [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]] | |||
|- | |- | ||
! style="text-align:left; text-indent:3em;" | - Other reasons | ! style="text-align:left; text-indent:3em;" | - Other reasons | ||
| [[Other reasons::{{{Other reasons|}}}]] | |||
|} | |} | ||
==Statistics== | ==Statistics== |
Revision as of 12:08, 28 August 2024
This is the "Further points for assessing the study" template.
It should be called in the following format:
{{Further points for assessing the study |Samples sufficiently large= |power analysis performed= |reasons given for samples= |Ethnicity mentioned= |Possibility of attention effects= |Possibility of placebo effects= |Other reasons= |Testing for normal distribution= |Correct application of statistical= |Correction for multiple testing= |Measurement of compliance= |Blinding reliable= |Check whether blinding was successful= |Consistent reporting in numbers= |Sufficient washout period= |Tested for carry-over= |Were sequence effects tested= |Comprehensive and coherent reporting= |Were side effects systematically recorded= |Effect sizes reported= |Side effects taken into account in the interpretation of the results= |mono- or multicentric= |Ethics / CoI / Funding= }}
Edit the page to see the template text.